ICD Scrutiny: Study Quantifies Significant Off-Guideline Implant Activity

The implantable defibrillator sector took another potential hit last week with findings that more than 20% of patients treated with the devices for primary prevention of sudden cardiac death should not receive them under current guidelines.

More from Archive

More from Medtech Insight